fluoxetine has been researched along with Dyskinesia, Drug-Induced in 26 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 26-year-old man with schizophrenia, disorganised type, and depression, developed severe tardive dyskinesia during treatment with risperidone and fluoxetine." | 3.70 | [Severe tardive dyskinesia during treatment with risperidone and fluoxetine]. ( Dubbelman, YD; Heeringa, M; Thung, FH, 1998) |
| "Patients who developed dystonia, parkinsonism, or tardive dyskinesia were older on average than patients with akathisia; 67." | 2.39 | Movement disorders associated with the serotonin selective reuptake inhibitors. ( Leo, RJ, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 20 (76.92) | 18.2507 |
| 2000's | 3 (11.54) | 29.6817 |
| 2010's | 2 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nevalainen, N | 1 |
| Af Bjerkén, S | 1 |
| Gerhardt, GA | 1 |
| Strömberg, I | 1 |
| Bhakta, SG | 1 |
| Andrade, C | 1 |
| Bishop, C | 1 |
| George, JA | 1 |
| Buchta, W | 1 |
| Goldenberg, AA | 1 |
| Mohamed, M | 1 |
| Dickinson, SO | 1 |
| Eissa, S | 1 |
| Eskow Jaunarajs, KL | 1 |
| Albertini, G | 3 |
| Majolini, L | 3 |
| Di Gennaro, G | 3 |
| Quarato, P | 3 |
| Scoppetta, C | 3 |
| Onorati, P | 3 |
| Chen, JJ | 1 |
| Swope, DM | 1 |
| Durif, F | 1 |
| Vidailhet, M | 1 |
| Bonnet, AM | 1 |
| Blin, J | 1 |
| Agid, Y | 1 |
| Hutson, PH | 1 |
| Bristow, LJ | 1 |
| Cunningham, JR | 1 |
| Hogg, JE | 1 |
| Longmore, J | 1 |
| Murray, F | 1 |
| Pearce, D | 1 |
| Razzaque, Z | 1 |
| Saywell, K | 1 |
| Tricklebank, MD | 1 |
| Mander, A | 1 |
| McCausland, M | 1 |
| Workman, B | 1 |
| Flamer, H | 1 |
| Christophidis, N | 1 |
| Sandler, NH | 1 |
| Fishbain, DA | 1 |
| Daniel, DG | 1 |
| Smith, K | 1 |
| Hyde, T | 1 |
| Egan, M | 1 |
| Bharucha, KJ | 1 |
| Sethi, KD | 1 |
| Dubovsky, SL | 1 |
| Thomas, M | 1 |
| Leo, RJ | 1 |
| Lauterbach, EC | 1 |
| Shillcutt, SD | 1 |
| Perucca, E | 1 |
| Marchioni, E | 1 |
| Soragna, D | 1 |
| Savoldi, F | 1 |
| Bates, GD | 1 |
| Khin-Maung-Zaw, F | 1 |
| Caley, CF | 1 |
| Dubbelman, YD | 1 |
| Thung, FH | 1 |
| Heeringa, M | 1 |
| Nielsen, AS | 1 |
| Mors, O | 1 |
| Brewerton, TD | 1 |
| Shannon, M | 1 |
| Budman, CL | 1 |
| Bruun, RD | 1 |
| Stein, MH | 1 |
| Sternbach, H | 1 |
| Fallon, BA | 1 |
| Liebowitz, MR | 1 |
| Lipinski, JF | 1 |
| Mallya, G | 1 |
| Zimmerman, P | 1 |
| Pope, HG | 1 |
2 reviews available for fluoxetine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Movement disorders associated with the serotonin selective reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Age Factors; Aged; Akathisia, Drug-Induced; Depressive Disorder; Dyskinesia, | 1996 |
The serotonin syndrome.
Topics: Adult; Antidepressive Agents; Basal Ganglia Diseases; Depressive Disorder; Drug Interactions; Drug T | 1991 |
24 other studies available for fluoxetine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Serotonergic nerve fibers in L-DOPA-derived dopamine release and dyskinesia.
Topics: Animals; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Female; Fluoxetine; Levodopa; Nerve Fi | 2014 |
Melatonin treatment of shoulder-and-neck dyskinesia possibly related to fluoxetine treatment.
Topics: Antioxidants; Dyskinesia, Drug-Induced; Fluoxetine; Humans; Male; Melatonin; Neck; Selective Seroton | 2009 |
Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats.
Topics: Animals; Antiparkinson Agents; Apomorphine; Biogenic Monoamines; Citalopram; Corpus Striatum; Dyskin | 2012 |
Oral dyskinesia induced by fluoxetine therapy for infantile autism.
Topics: Autistic Disorder; Dyskinesia, Drug-Induced; Fluoxetine; Humans; Infant; Male; Selective Serotonin R | 2004 |
A case of complex movement disorder induced by fluoxetine with management of dystonia by botulinum toxin type A.
Topics: Aged; Anti-Dyskinesia Agents; Botulinum Toxins, Type A; Dyskinesia, Drug-Induced; Dystonic Disorders | 2005 |
Levodopa-induced dyskinesias are improved by fluoxetine.
Topics: Antiparkinson Agents; Apomorphine; Dyskinesia, Drug-Induced; Fluoxetine; Humans; Levodopa; Middle Ag | 1995 |
The effects of GR127935, a putative 5-HT1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HT concentration and behaviour in the guinea pig.
Topics: Animals; Biogenic Monoamines; Brain; Dyskinesia, Drug-Induced; Electric Stimulation; Fluoxetine; Gui | 1995 |
Fluoxetine induced dyskinesia.
Topics: Aged; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Fluoxetine; Humans | 1994 |
Tardive dyskinesia associated with fluoxetine.
Topics: Adult; Clomipramine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Fluoxetine; Humans; Male; | 1996 |
Fluoxetine and extrapyramidal side effects.
Topics: Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Fluoxetine; Humans; Selective Serotonin Reuptake I | 1996 |
Neuroleptic-induced tardive dyskinesia.
Topics: Adolescent; Basal Ganglia Diseases; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Fluoxetine; | 1996 |
Complex movement disorders induced by fluoxetine.
Topics: Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Dyskinesia, Drug-Induced; Femal | 1996 |
Tardive dyskinesia associated with fluoxetine.
Topics: Adult; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Fluoxetine; Humans; Middle Aged; Selec | 1996 |
Dyskinesia with fluoxetine: tardive or late-onset persistent, acute norfluoxetine dyskinesia?
Topics: Acute Disease; Animals; Diagnosis, Differential; Dyskinesia, Drug-Induced; Fluoxetine; Humans; Movem | 1997 |
Fluoxetine-induced movement disorders and deficient CYP2D6 enzyme activity.
Topics: Aged; Cytochrome P-450 CYP2D6; Drug Interactions; Dyskinesia, Drug-Induced; Female; Fluoxetine; Huma | 1997 |
Movement disorder with fluoxetine.
Topics: Antidepressive Agents, Second-Generation; Child; Depression; Dyskinesia, Drug-Induced; Female; Fluox | 1998 |
Extrapyramidal reactions from concurrent SSRI and atypical antipsychotic use.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsych | 1998 |
[Severe tardive dyskinesia during treatment with risperidone and fluoxetine].
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Fluoxetine; Humans | 1998 |
Choreiform dyskinesia with acute onset and protracted course following fluoxetine treatment.
Topics: Acute Disease; Chorea; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Fluoxetine; Humans; Mi | 1999 |
Possible clozapine exacerbation of bulimia nervosa.
Topics: Acute Disease; Adult; Bulimia; Clozapine; Dyskinesia, Drug-Induced; Female; Fluoxetine; Humans; Recu | 1992 |
Persistent dyskinesia in a patient receiving fluoxetine.
Topics: Adult; Basal Ganglia Diseases; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Fluoxetine; Hu | 1991 |
Tardive dyskinesia in a patient taking haloperidol and fluoxetine.
Topics: Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Fluoxe | 1991 |
Fluoxetine and extrapyramidal symptoms in CNS lupus.
Topics: Adult; Basal Ganglia Diseases; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Fluoxetine; Hu | 1991 |
Fluoxetine-induced akathisia: clinical and theoretical implications.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Depressive Disorder; Dopamine; Dyskinesia, Drug-Induced; | 1989 |